Aligos Therapeutics, Inc. (NASDAQ:ALGS) IPO
IPO
Priced at US$15.00 a share on Oct 15, 2020.
- Price
- US$15.00 a share
- Shares offered
- 10,000,000 shares of common stock
- Offering size
- US$150 million
- Underwriters' option
- Up to 1,500,000 more shares
- Underwriters
- J.P. Morgan, Jefferies, Piper Sandler, Cantor · In the order on the cover
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Aug 26, 2020 |
| Filed publicly | Sep 25, 2020 |
| Amended once | Oct 9, 2020 |
| Shares registered with an exchange | Oct 13, 2020 |
| Declared effective by the SEC | Oct 15, 2020 |
| Final prospectus, with the price | Oct 19, 2020 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Oct 19, 2020 |
| EFFECT · Notice that a registration is effective | Oct 15, 2020 |
| CERT · Exchange's certificate of listing | Oct 14, 2020 |
| CORRESP · Letter to the SEC | Oct 13, 2020 |
| CORRESP · Letter to the SEC | Oct 13, 2020 |
| 8-A12B · Registration of shares for listing on an exchange | Oct 13, 2020 |
| S-1/A · Registration statement, amended | Oct 9, 2020 |
| CORRESP · Letter to the SEC | Oct 2, 2020 |
| CORRESP · Letter to the SEC | Sep 25, 2020 |
| S-1 · Registration statement | Sep 25, 2020 |
| UPLOAD · Letter from the SEC | Sep 23, 2020 |
| DRS · Draft registration statement | Aug 26, 2020 |
From the cover of the final prospectus (424B4) filed Oct 19, 2020